Literature DB >> 23832143

Virulence factor expression patterns in Pseudomonas aeruginosa strains from infants with cystic fibrosis.

J Manos1, H Hu, B R Rose, C E Wainwright, I B Zablotska, J Cheney, L Turnbull, C B Whitchurch, K Grimwood, C Harmer, S N Anuj, C Harbour.   

Abstract

Pseudomonas aeruginosa is the leading cause of morbidity and mortality in cystic fibrosis (CF). This study examines the role of organism-specific factors in the pathogenesis of very early P. aeruginosa infection in the CF airway. A total of 168 longitudinally collected P. aeruginosa isolates from children diagnosed with CF following newborn screening were genotyped by pulsed-field gel electrophoresis (PFGE) and phenotyped for 13 virulence factors. Ninety-two strains were identified. Associations between virulence factors and gender, exacerbation, persistence, timing of infection and infection site were assessed using multivariate regression analysis. Persistent strains showed significantly lower pyoverdine, rhamnolipid, haemolysin, total protease, and swimming and twitching motility than strains eradicated by aggressive antibiotic treatments. Initial strains had higher levels of virulence factors, and significantly higher phospholipase C, than subsequent genotypically different strains at initial isolation. Strains from males had significantly lower pyoverdine and swimming motility than females. Colony size was significantly smaller in strains isolated during exacerbation than those isolated during non-exacerbation periods. All virulence factors were higher and swimming motility significantly higher in strains from bronchoalveolar lavage (BAL) and oropharyngeal sites than BAL alone. Using unadjusted regression modelling, age at initial infection and age at isolation of a strain showed U-shaped profiles for most virulence factors. Among subsequent strains, longer time since initial infection meant lower levels of most virulence factors. This study provides new insight into virulence factors underpinning impaired airway clearance seen in CF infants, despite aggressive antibiotic therapy. This information will be important in the development of new strategies to reduce the impact of P. aeruginosa in CF.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23832143     DOI: 10.1007/s10096-013-1916-7

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  37 in total

1.  Effect of bronchoalveolar lavage-directed therapy on Pseudomonas aeruginosa infection and structural lung injury in children with cystic fibrosis: a randomized trial.

Authors:  Claire E Wainwright; Suzanna Vidmar; David S Armstrong; Catherine A Byrnes; John B Carlin; Joyce Cheney; Peter J Cooper; Keith Grimwood; Marj Moodie; Colin F Robertson; Harm A Tiddens
Journal:  JAMA       Date:  2011-07-13       Impact factor: 56.272

2.  Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.

Authors:  Eric E Smith; Danielle G Buckley; Zaining Wu; Channakhone Saenphimmachak; Lucas R Hoffman; David A D'Argenio; Samuel I Miller; Bonnie W Ramsey; David P Speert; Samuel M Moskowitz; Jane L Burns; Rajinder Kaul; Maynard V Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-10       Impact factor: 11.205

3.  Imaging and analysis of Pseudomonas aeruginosa swarming and rhamnolipid production.

Authors:  Joshua D Morris; Jessica L Hewitt; Lawrence G Wolfe; Nachiket G Kamatkar; Sarah M Chapman; Justin M Diener; Andrew J Courtney; W Matthew Leevy; Joshua D Shrout
Journal:  Appl Environ Microbiol       Date:  2011-10-07       Impact factor: 4.792

4.  Prc protease promotes mucoidy in mucA mutants of Pseudomonas aeruginosa.

Authors:  S A Reiling; J A Jansen; B J Henley; S Singh; C Chattin; M Chandler; D W Rowen
Journal:  Microbiology (Reading)       Date:  2005-07       Impact factor: 2.777

Review 5.  Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing.

Authors:  F C Tenover; R D Arbeit; R V Goering; P A Mickelsen; B E Murray; D H Persing; B Swaminathan
Journal:  J Clin Microbiol       Date:  1995-09       Impact factor: 5.948

6.  Metabolic network analysis of Pseudomonas aeruginosa during chronic cystic fibrosis lung infection.

Authors:  Matthew A Oberhardt; Joanna B Goldberg; Michael Hogardt; Jason A Papin
Journal:  J Bacteriol       Date:  2010-08-13       Impact factor: 3.490

7.  Identification and characterization of genes for a second anthranilate synthase in Pseudomonas aeruginosa: interchangeability of the two anthranilate synthases and evolutionary implications.

Authors:  D W Essar; L Eberly; A Hadero; I P Crawford
Journal:  J Bacteriol       Date:  1990-02       Impact factor: 3.490

8.  The Pseudomonas aeruginosa oxidative stress regulator OxyR influences production of pyocyanin and rhamnolipids: protective role of pyocyanin.

Authors:  Tiffany Vinckx; Qing Wei; Sandra Matthijs; Pierre Cornelis
Journal:  Microbiology (Reading)       Date:  2009-11-19       Impact factor: 2.777

9.  Swarming motility, secretion of type 3 effectors and biofilm formation phenotypes exhibited within a large cohort of Pseudomonas aeruginosa clinical isolates.

Authors:  Thomas S Murray; Michel Ledizet; Barbara I Kazmierczak
Journal:  J Med Microbiol       Date:  2010-01-21       Impact factor: 2.472

10.  Positive signature-tagged mutagenesis in Pseudomonas aeruginosa: tracking patho-adaptive mutations promoting airways chronic infection.

Authors:  Irene Bianconi; Andrea Milani; Cristina Cigana; Moira Paroni; Roger C Levesque; Giovanni Bertoni; Alessandra Bragonzi
Journal:  PLoS Pathog       Date:  2011-02-03       Impact factor: 6.823

View more
  11 in total

1.  Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis.

Authors:  Nicole Mayer-Hamblett; Bonnie W Ramsey; Hemantha D Kulasekara; Daniel J Wolter; Laura S Houston; Christopher E Pope; Bridget R Kulasekara; Catherine R Armbruster; Jane L Burns; George Retsch-Bogart; Margaret Rosenfeld; Ronald L Gibson; Samuel I Miller; Umer Khan; Lucas R Hoffman
Journal:  Clin Infect Dis       Date:  2014-05-26       Impact factor: 9.079

2.  Coculture of Staphylococcus aureus with Pseudomonas aeruginosa Drives S. aureus towards Fermentative Metabolism and Reduced Viability in a Cystic Fibrosis Model.

Authors:  Laura M Filkins; Jyoti A Graber; Daniel G Olson; Emily L Dolben; Lee R Lynd; Sabin Bhuju; George A O'Toole
Journal:  J Bacteriol       Date:  2015-04-27       Impact factor: 3.490

3.  Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes.

Authors:  Nicole Mayer-Hamblett; Margaret Rosenfeld; Ronald L Gibson; Bonnie W Ramsey; Hemantha D Kulasekara; George Z Retsch-Bogart; Wayne Morgan; Daniel J Wolter; Christopher E Pope; Laura S Houston; Bridget R Kulasekara; Umer Khan; Jane L Burns; Samuel I Miller; Lucas R Hoffman
Journal:  Am J Respir Crit Care Med       Date:  2014-08-01       Impact factor: 21.405

4.  Chronic infection phenotypes of Pseudomonas aeruginosa are associated with failure of eradication in children with cystic fibrosis.

Authors:  P Vidya; L Smith; T Beaudoin; Y C Yau; S Clark; B Coburn; D S Guttman; D M Hwang; V Waters
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01       Impact factor: 3.267

Review 5.  Pseudomonas aeruginosa Diversification during Infection Development in Cystic Fibrosis Lungs-A Review.

Authors:  Ana Margarida Sousa; Maria Olívia Pereira
Journal:  Pathogens       Date:  2014-08-18

6.  Phenotypic and Genotypic Comparison of Epidemic and Non-Epidemic Strains of Pseudomonas aeruginosa from Individuals with Cystic Fibrosis.

Authors:  Jessica Duong; Sean C Booth; Nathan K McCartney; Harvey R Rabin; Michael D Parkins; Douglas G Storey
Journal:  PLoS One       Date:  2015-11-23       Impact factor: 3.240

7.  Sputum microbiota associated with new, recurrent and treatment failure tuberculosis.

Authors:  Jing Wu; Wei Liu; Lei He; Fuli Huang; Jiazhen Chen; Peng Cui; Yaojie Shen; Jing Zhao; Wenjie Wang; Yan Zhang; Min Zhu; Wenhong Zhang; Ying Zhang
Journal:  PLoS One       Date:  2013-12-13       Impact factor: 3.240

8.  Proteomic analysis of keratitis-associated Pseudomonas aeruginosa.

Authors:  Abby Sewell; Jeffrey Dunmire; Michael Wehmann; Theresa Rowe; Rachida Bouhenni
Journal:  Mol Vis       Date:  2014-08-29       Impact factor: 2.367

9.  Within-Host Evolution of the Dutch High-Prevalent Pseudomonas aeruginosa Clone ST406 during Chronic Colonization of a Patient with Cystic Fibrosis.

Authors:  Rosa van Mansfeld; Mark de Been; Fernanda Paganelli; Lei Yang; Marc Bonten; Rob Willems
Journal:  PLoS One       Date:  2016-06-23       Impact factor: 3.240

10.  Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis.

Authors:  Kate Skolnik; Austin Nguyen; Ranjani Somayaji; Christina S Thornton; Barbara Waddell; Michael G Surette; Harvey R Rabin; Michael D Parkins
Journal:  BMC Pulm Med       Date:  2015-12-12       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.